JAZZNasdaq Ireland
Market cap
$16.654 B
$256.56 -0.04%
Close of 7 Aug 2026
Revenue
$4.27B
#747 by revenue
Earnings
-$356.1M
Loss-making
Shares outstanding
64,914,577
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Jazz Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.